Methods and systems for treatment of
coronary artery disease (CAD) include implantation of the
discharge portion(s) of a
catheter and, optionally, electrodes on a lead, near the tissue(s) to be stimulated. Stimulation pulses, i.e.,
drug infusion pulses and optional electrical pulses, are supplied by a stimulator implanted remotely, and through the
catheter or lead, which is tunneled subcutaneously between the stimulator and stimulation site. Stimulation sites include the
coronary arteries, the
aorta, the left
ventricle, the
left atrium, and / or the pulmonary veins, among other locations. Disclosed treatments include drugs used for acute treatment of CAD, for chronic treatment of CAD, to promote
angiogenesis, and / or as AGE Crosslink Breakers, among other drugs. For instance, the systems and methods reduce or eliminate the incidence of CAD and related morbidities, improve symptoms resulting from CAD, and / or improve cardiac
blood flow, cardiac function, and patient
quality of life.